We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Varian Medical Systems

Provides solutions for advancing cancer treatment, radiosurgery, X-ray imaging, & security, radiotherapy, radiosurger... read more Featured Products: More products

Download Mobile App




Adaptive Proton RT Democratizes Cancer Care

By MedImaging International staff writers
Posted on 20 Feb 2020
Print article
Image: The Varian Probeam proton therapy System (Photo courtesy of Varian)
Image: The Varian Probeam proton therapy System (Photo courtesy of Varian)
An artificial intelligence (AI)-driven radiotherapy (RT) solution delivers a holistic adaptive treatment experience to improve patient care.

The Varian Medical Systems (Varian; Palo Alto, CA, USA) Ethos therapy, built on Varian's treatment delivery technology, is designed to provide a streamlined workflow enabled by AI-driven planning and contouring capabilities. The physician first defines clinical intent from pre-defined templates, and the preliminary treatment plan is generated based on the physician's initial clinical objectives. Treatment is then adapted in response to any changes in the patient's anatomy and the tumor's shape and position, on-couch and at the time of treatment.

By providing an up-to-date view of the patient's anatomy, Ethos therapy allows clinicians to make more informed adaptive treatment decisions. Ethos therapy offers the use of multimodality images, including magnetic resonance imaging (MRI), positron emission tomography (PET), computerized tomography (CT), and daily iterative cone beam computerized tomography (CBCT) images at the console itself. The entire process occupies a typical 15-minute timeslot, from initial patient setup on the couch and through treatment delivery.

“Ethos is the long-awaited solution that puts each patient truly at the center of care. This solution represents a new chapter in democratized cancer care," said Chris Toth, president of Varian Oncology Systems. “With Ethos, on-couch adaptive therapy is no longer an elusive aspiration that is too complex and time-consuming to be practical, and too exclusive for most clinics and patients. This is another important step in cancer care that moves us closer to achieving our vision of a world without fear of cancer.”

“Ethos therapy will enable our physicians to better visualize the changes in a patient's anatomy and quickly adapt the therapy accordingly to help provide better treatments to patients,” said Poul Geertsen, MD, PhD, head of radiotherapy at Herlev and Gentofte Hospital (Copenhagen, Denmark). “We have already delivered the first Ethos therapy treatment, and our clinical staff was impressed by the capabilities and the ability to deliver this advanced treatment in a typical timeslot.”

Varian specializes in proton therapy, a precise form of RT that uses charged particles instead of x-rays. It can be a more effective form of treatment than conventional RT as it is more precise, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom it appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.

Related Links:
Varian Medical Systems

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
40/80-Slice CT System
uCT 528
New
Gold Member
X-Ray QA Meter
T3 RG Pro
New
Ultrasound Imaging System
P12 Elite

Print article

Channels

MRI

view channel
Image: MRI microscopy of mouse and human pancreas with respective histology demonstrating ability of DTI maps to identify pre-malignant lesions (Photo courtesy of Bilreiro C, et al. Investigative Radiology, 2024)

Pioneering MRI Technique Detects Pre-Malignant Pancreatic Lesions for The First Time

Pancreatic cancer is the leading cause of cancer-related fatalities. When the disease is localized, the five-year survival rate is 44%, but once it has spread, the rate drops to around 3%.... Read more

Ultrasound

view channel
Image: A transparent ultrasound transducer-based photoacoustic-ultrasound fusion probe, along with images of a rat’s rectum and a pig’s esophagus (Photo courtesy of POSTECH)

Transparent Ultrasound Transducer for Photoacoustic and Ultrasound Endoscopy to Improve Diagnostic Accuracy

Endoscopic ultrasound is a commonly used tool in gastroenterology for cancer diagnosis; however, it provides limited contrast in soft tissues and only offers structural information, which reduces its diagnostic... Read more

General/Advanced Imaging

view channel
Image: The results of the eight-view 3D CT reconstruction from a public dataset (Photo courtesy of Medical Physics, doi.org/10.1002/mp.12345)

AI Model Reconstructs Sparse-View 3D CT Scan With Much Lower X-Ray Dose

While 3D CT scans provide detailed images of internal structures, the 1,000 to 2,000 X-rays captured from different angles during scanning can increase cancer risk, especially for vulnerable patients.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.